Manuel Vázquez-Carrera (Manel Vazquez-Carrera)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Insulin Resistance

Oxide Nanoparticles

Cognitive Impairment

Top Venues

International journal of molecular sciences

Journal of neurochemistry

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Meijian Zhang, Andrea Bagán, Donna Martínez, Emma Barroso, Xavier Palomer, Santiago Vázquez, Carmen Escolano, Manuel Vázquez-Carrera
Design and Synthesis of AMPK Activators and GDF15 Inducers. Molecules (Basel, Switzerland) 28 (14) (2023)
Manuel Vázquez-Carrera, Walter Wahli
PPARs as Key Mediators in the Regulation of Metabolism and Inflammation. International journal of molecular sciences 23 (9) (2022)
Victor García-Torra, Amanda Cano, Marta Espina, Miren Etchetto, Antonio Camins Espuny, Emma Barroso, Manuel Vázquez-Carrera, Maria Luisa García, Elena Sánchez-Lopez, Eliana Barbosa Souto
State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. Toxics 9 (8) (2021)
David Aguilar-Recarte, Xavier Palomer, Walter Wahli, Manuel Vázquez-Carrera
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance. International journal of molecular sciences 22 (16) (2021)
Emma Barroso, Rosalía Rodríguez-Rodríguez, Mohammad Zarei, Javier Pizarro-Degado, Anna Planavila, Xavier Palomer, Francesc Villarroya, Manuel Vázquez-Carrera
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2. Cell communication and signaling : CCS 18 (1) (2020)
Xavier Palomer, M Silvia Román-Azcona, Javier Pizarro-Delgado, Ana Planavila, Francesc Villarroya, Brenda Valenzuela-Alcaraz, Fátima Crispi, Álvaro Sepúlveda-Martínez, Irene Miguel-Escalada, Jorge Ferrer, J Francisco Nistal, Raquel García, Mercy M Davidson, Emma Barroso, Manuel Vázquez-Carrera
SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation. Signal transduction and targeted therapy 5 (1) (2020)
Mohammad Zarei, Eugènia Pujol, Tania Quesada-López, Francesc Villarroya, Emma Barroso, Santiago Vázquez, Javier Pizarro-Delgado, Xavier Palomer, Manuel Vázquez-Carrera
Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21. British journal of pharmacology 176 (13) (2019)
Oriol Busquets, Àuria Eritja, Blanca M López, Miren Ettcheto, Patricia Regina Manzine, Rubén D Castro-Torres, Ester Verdaguer, Jordi Olloquequi, Manuel Vázquez-Carrera, Carme Auladell, Jaume Folch, Antonio Camins Espuny
Role of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model. Journal of neurochemistry 149 (2) (2019)
Xavier Palomer, Emma Barroso, Javier Pizarro-Delgado, Lucía Peña, Gaia Botteri, Mohammad Zarei, David Aguilar, Marta Montori-Grau, Manuel Vázquez-Carrera
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders. International journal of molecular sciences 19 (3) (2018)